William Edmiston, MD
Interventional Pain Medicine · Mooresville, NCNPI 1053420190
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,401 of the $4,069 with a category attached, or 83.6%. Boston Scientific accounts for 72.0% of it on its own, with 19 other manufacturers making up the rest.
Across 81 payments — averaging $50.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Collegium Pharmaceutical, Inc.$219
- Medtronic$126
- SPR Therapeutics, Inc$117
- Daiichi Sankyo Inc.$109
- Biodelivery Sciences International, Inc.$81
- plus $489 from 14 others
What the payments were for
- Travel & lodging$66816%
- Food & beverage$3,40184%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 36 | $2,928 |
| Collegium Pharmaceutical, Inc. | 8 | $219 |
| Medtronic | 1 | $126 |
| SPR Therapeutics, Inc | 2 | $117 |
| Daiichi Sankyo Inc. | 7 | $109 |
| Biodelivery Sciences International, Inc. | 7 | $81 |
| Forte Bio-pharma LLC | 2 | $74 |
| GRT US Holding, Inc. | 1 | $67 |
| Vertex | 1 | $61 |
| Arbor Pharmaceuticals, Inc. | 4 | $61 |
| Scilex Pharmaceuticals Inc. | 1 | $53 |
| Zyla Life Sciences, Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Shionogi Inc | 1 | $25 |
| Terumo Medical Corporation | 1 | $17 |
| Pfizer | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Pernix Therapeutics Holdings, Inc. | 1 | $15 |
| Assertio Therapeutics, Inc. | 1 | $12 |
| Kaleo, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,069 in reported general payments places this provider in the 55th percentile of 45 interventional pain medicine providers in North Carolina.
See all interventional pain medicine providers in North Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 67 | $66,136 |
| Buprenorphine | 222 | $60,783 |
| Oxycodone Hcl | 1,327 | $37,055 |
| Fentanyl | 192 | $26,006 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 659 | $25,097 |
| OxycontinOxycodone Hcl | 24 | $20,232 |
| MovantikNaloxegol Oxalate | 49 | $19,338 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 331 | $18,286 |
| Morphine Sulfate ErMorphine Sulfate | 417 | $15,987 |
| BelbucaBuprenorphine Hcl | 19 | $14,517 |
| Gabapentin | 314 | $4,811 |
| Pregabalin | 228 | $4,032 |
| Tramadol Hcl | 162 | $3,434 |
| Morphine Sulfate | 81 | $3,240 |
| Hydromorphone ErHydromorphone Hcl | 12 | $3,193 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca | $219 | $80,65386 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 45 interventional pain medicine providers in North Carolina.
Other interventional pain medicine in Mooresville
- Mark HinesMooresville$6K
- Timothy ChafinAhoskie$59K
- Robert WilsonSalisbury$37K
- John MansfieldAsheville$25K
- Erin ChaneyJacksonville$22K
- Kevin CostelloGreenville$22K
- Scott JohnstonJacksonville$20K
- Harsh GovilStatesville$19K
- Troy GingerichCharlotte$19K
- Brent HarkriderNew Bern$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.